4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-013468
EVP, COO, Head of Commercial sold 461 shares at $18.78 ($8,658)
- EVP, COO, Head of Commercial acquired 1,107 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2023-02-23 | Option exercise | +1,107 | 5,656 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-02-24 | Sale | −461 | $18.78 | $8,658 | 5,195 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-02-23 | Option exercise · Restricted Stock Units | −1,107 | 2,214 | D | ||
| Open-market sales · 461 sh · avg $18.78 · $8,658 | |||||||
Loading xslF345X03/doc4.xml…